Avalo Therapeutics, Inc. (AVTX)
20.04
+0.80
(+4.16%)
USD |
NASDAQ |
Dec 10, 16:00
20.00
-0.04
(-0.20%)
After-Hours: 20:00
Avalo Therapeutics EPS Diluted (Quarterly): -2.187 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rocket Pharmaceuticals, Inc. | -0.4511 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
| Oragenics, Inc. | -1.965 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -30.62M |
| Total Expenses (Quarterly) | 30.62M |
| Enterprise Value | 239.75M |
| Earnings Yield | -43.56% |
| Normalized Earnings Yield | -32.03 |